Synthetic Biotechnology to Study and Engineer Ribosomal Bottromycin Biosynthesis
Dr Shwan Rachid and his co-author has published a new article in Chemistry & Biology, Volume 19, Issue 10, 1278-1287, 27 September 2012. The new publication covers Bottromycins which represent a promising class of antibiotics binding to the therapeutically unexploited A-site of the bacterial ribosome. The compounds inhibit bacterial translation process, and they are active against clinically important and multidrug-resistant pathogens.